Literature DB >> 3498535

New n.m.r.-spectroscopic approaches for structural studies of polysaccharides: application to the Haemophilus influenzae type a capsular polysaccharide.

R A Byrd1, W Egan, M F Summers, A Bax.   

Abstract

The extension of several modern nuclear magnetic resonance (n.m.r.) spectroscopic techniques to polysaccharides is discussed and illustrated, using the native Haemophilus influenzae type a capsular polysaccharide. These techniques provide for the unambiguous assignment of all n.m.r. resonances (1H, 13C, and 31P) via high-sensitivity homonuclear and 1H-detected heteronuclear correlations, and they are capable of locating the intersaccharide linkages (both O-linked and phosphoric diester-linked) and appended groups (e.g. O-acetyl groups). To illustrate the power and sensitivity of these methods, a 10-mg sample of the H. Influenzae type a polysaccharide (repeat unit mol. wt. = 376) was studied. The combined acquisition time for the two-dimensional 1H-13C correlation data (one-bond and multiple-bond), the 1H-31P correlation data, and the 1H-1H (homonuclear Hartmann-Hahn) data was approximately 18 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498535     DOI: 10.1016/0008-6215(87)80043-5

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

Review 1.  Haemophilus influenzae type a infection and its prevention.

Authors:  Zhigang Jin; Sandra Romero-Steiner; George M Carlone; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

2.  Heteronuclear NMR studies of 13C-labeled yeast cell wall beta-glucan oligosaccharides.

Authors:  L Yu; R Goldman; P Sullivan; G F Walker; S W Fesik
Journal:  J Biomol NMR       Date:  1993-07       Impact factor: 2.835

Review 3.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.